SBRT combined with concurrent chemoradiation in stage III NSCLC: Feasibility study of the phase I Hybrid trial.

CONCLUSIONS: SBRT and FRT could be combined within the given OAR constraints. Safety will be assessed in the Hybrid trial.
PMID: 31431387 [PubMed - as supplied by publisher]

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - August 16, 2019 Category: Radiology Authors: Peulen H, Franssen G, Belderbos J, van der Bijl E, Tijhuis A, Rossi M, Sonke JJ, Damen E Tags: Radiother Oncol Source Type: research